Determination of Drugs in Clinical Trials: Current Status and Outlook

Abstract

All pharmaceutical drugs, vaccines, cosmetic products, and many medical breakthroughs must first be approved through clinical research and trials before advancing to standard practice or entering the marketplace. Clinical trials are sets of tests that are required to determine the safety and efficacy of pharmaceutical compounds, drugs, and treatments. There is one pre-phase and four main clinical phase requirements that every drug must pass to obtain final approval. Analytical techniques play a unique role in clinical trials for measuring the concentrations of pharmaceutical compounds in biological matrices and monitoring the conditions of patients (or volunteers) during various clinical phases. This review focuses on recent analytical methods that are employed to determine the concentrations of drugs and medications in biological matrices, including whole blood, plasma, urine, and breast milk. Four primary analytical techniques (extraction, spectroscopy, chromatography, and electrochemical) are discussed, and their advantages and limitations are assessed. Subsequent to a survey of evidence and results, it is clear that microelectromechanical system (MEMS) based electrochemical sensor and biosensor technologies exhibit several notable advantages over other analytical methods, and their future prospects are discussed.

E-Health & Innovation to Overcome Barriers in Neuromuscular Diseases. Report from the 3rd eNMD Congress: Pisa, Italy, 29–30 October 2021

“…Currently none of the available biosensors holds direct promise for NMDs, but some analytes such as creatine kinase, lactate or glucose might be worth exploring in depth to assess muscle fiber integrity or the effects of pharmacological therapies. The clinical studies needed to confirm the benefits of such biosensors and systems could themselves benefit from the new possibilities offered by TM, shortening the time and reducing the costs required for their implementation [30].…”

Fabrication and employment of cobalt-doped yttrium iron garnets for the electrochemical analysis of anti-diabetic, metformin in serum of type 2 diabetes mellitus patients

“…Small amplitude alternating potential is applied, and response is measured. It comprises of frequency generator, frequency response analyzer (heart of EIS system), electrochemical cell, and analytes [ 15 , 16 ].…”